Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1. | Commun Biol | 2021 | 34725466 | PubTator, text mining | PubMed |
| ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway. | Cell Death Dis | 2021 | 34725332 | PubTator, text mining | PubMed |
| NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression. | Front Oncol | 2021 | 34722240 | PubTator, text mining | PubMed |
| Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway. | Virol J | 2021 | 34717661 | PubTator, text mining | PubMed |
| Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program. | Adv Sci (Weinh) | 2021 | 34716691 | PubTator, text mining | PubMed |
| BET protein inhibition evidently enhances sensitivity to PI3K/mTOR dual inhibition in intrahepatic cholangiocarcinoma. | Cell Death Dis | 2021 | 34716294 | PubTator, text mining | PubMed |
| Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics. | Cancer Cell Int | 2021 | 34715855 | PubTator, text mining | PubMed |
| WW Domain-Containing E3 Ubiquitin Protein Ligase 1: A Self-Disciplined Oncoprotein. | Front Cell Dev Biol | 2021 | 34712671 | PubTator, text mining | PubMed |
| Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1. | Biol Open | 2021 | 34693980 | PubTator, text mining | PubMed |
| Identification of Components of the Hippo Pathway in Hydra and Potential Role of YAP in Cell Division and Differentiation. | Front Genet | 2021 | 34691138 | PubTator, text mining | PubMed |
| Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine. | Cells | 2021 | 34685695 | PubTator, text mining | PubMed |
| LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2021 | 34681854 | PubTator, text mining | PubMed |
| Plant Polyphenols for Aging Health: Implication from Their Autophagy Modulating Properties in Age-Associated Diseases. | Pharmaceuticals (Basel) | 2021 | 34681206 | PubTator, text mining | PubMed |
| Hepatocyte Polyploidy: Driver or Gatekeeper of Chronic Liver Diseases. | Cancers (Basel) | 2021 | 34680300 | PubTator, text mining | PubMed |
| Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance. | Cancers (Basel) | 2021 | 34680275 | PubTator, text mining | PubMed |
| Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers. | Cancers (Basel) | 2021 | 34680208 | PubTator, text mining | PubMed |
| Long non-coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA-193a-5p/NETO2 axis. | Oncol Lett | 2021 | 34671432 | PubTator, text mining | PubMed |
| The Hippo pathway: a renewed insight in the craniofacial diseases and hard tissue remodeling. | Int J Biol Sci | 2021 | 34671220 | PubTator, text mining | PubMed |
| Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. | Oncogene | 2021 | 34663879 | PubTator, text mining | PubMed |
| Comprehensive Genomic Characterization Analysis Identifies an Oncogenic Pseudogene RP11-3543B.1 in Human Gastric Cancer. | Front Cell Dev Biol | 2021 | 34660601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=53